Author:
Yang Shigui,Tian Guo,Cui Yuanxia,Ding Cheng,Deng Min,Yu Chengbo,Xu Kaijin,Ren Jingjing,Yao Jun,Li Yiping,Cao Qing,Chen Ping,Xie Tiansheng,Wang Chencheng,Wang Bing,Mao Chen,Ruan Bing,Jiang Tian’an,Li Lanjuan
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Lavanchy, D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis 11, 97–107 (2004).
2. European Centre for Disease Prevention and Control. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. European Centre for Disease Prevention and Control. 56 p. doi: 10.2900/30933 (Stockholm, 2010).
3. Hahne, S. J. et al. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC infectious diseases 13, 181, doi: 10.1186/1471-2334-13-181 (2013).
4. Keck, J. W. et al. Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native persons. Clinical and vaccine immunology: CVI 21, 1339–1342, doi: 10.1128/CVI.00263-14 (2014).
5. Bruce, M. G. et al. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. The Journal of infectious diseases, doi: 10.1093/infdis/jiv748 (2016).
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献